A recent study reveals that the timing of a woman's first menstrual period can predict long-term health risks, including obesity and diabetes. Discover the implications of early and late menarche on ...

Lucknow: Childhood obesity is emerging as a major health concern in the city, with doctors warning that it is leading to ...

The new study found that Midwestern states had the highest rates of obesity-linked cancer deaths, while the Northeast fared ...

Intermittent energy restriction, time-restricted eating and continuous energy restriction can all improve blood sugar levels ...

In patients with acquired hypothalamic obesity, setmelanotide reduced BMI at 52 weeks compared with placebo, according to results of the TRANSCEND trial presented at ENDO 2025. For the phase 3 trial, ...

Obesity-related cancer deaths increased more than threefold between 1999 and 2020, according to an analysis of the CDC WONDER ...

Cancer deaths linked to obesity have tripled in the United States over the past two decades, according to a study being ...

Remember former Rep. Jamaal Bowman (D-N.Y.) who got censured for pulling the fire alarm in the Capitol Building as lawmakers ...

Postmenopausal women struggling with weight loss may find a powerful solution by combining the diabetes drug tirzepatide with menopause hormone therapy. A Mayo Clinic study revealed that this dual ...

Women and older adults taking the anti-obesity drug semaglutide may be at higher risk for muscle loss, but higher protein intake may help prevent muscle loss in these patients, according to a small ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...